Human cell lines engineered for tetracycline-regulated expression of tumor suppressor candidate genes from a frequently affected chromosomal region, 3p21

Journal of Gene Medicine

Volumn 4, Issue 4, 2002, Pages 397-406

  Protopopov, Alexei I ^a,b   Li, Jinfeng ^a   Winberg, Gösta ^a   Gizatullin, Rinat Z ^a,c   Kashuba, Vladimir I ^a,d   Klein, George ^a   Zabarovsky, Eugene R ^a,c,e  

^a KAROLINSKA INSTITUTE   (Sweden)

^b INSTITUTE OF CYTOLOGY AND GENETICS   (Russian Federation)

^c KAROLINSKA INSTITUTE   (Sweden)

^d INSTITUTE OF MOLECULAR BIOLOGY AND GENETICS   (Ukraine)

^e ENGELHARDT INSTITUTE OF MOLECULAR BIOLOGY   (Russian Federation)

Author keywords

Chromosome 3p kinase; Epstein Barr virus (EBV); Gene expression regulation; Gene inactivation test; Human MLH1 protein; Tetracycline

Indexed keywords

DRINKING WATER; HYGROMYCIN; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN MLH1; RETROVIRUS VECTOR; TETRACYCLINE; CARRIER PROTEIN; MAP KINASE ACTIVATED KINASE 3; MAP-KINASE-ACTIVATED KINASE 3; MLH1 PROTEIN, HUMAN; MLH1 PROTEIN, MOUSE; NUCLEAR PROTEIN; PROTEIN SERINE THREONINE KINASE; TUMOR PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CELL SELECTION; CHROMOSOME 3P; CHROMOSOME BAND; CONTROLLED STUDY; EPISOME; EXPERIMENTAL DESIGN; EXPRESSION VECTOR; GENE EXPRESSION; GENE REPLICATION; GENE TARGETING; GENETIC CODE; GENETIC ENGINEERING; GENETIC REGULATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HUMAN CYTOMEGALOVIRUS; IN VIVO STUDY; MOLECULAR CLONING; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PLASMID; PRIMATE; PRIORITY JOURNAL; SCID MOUSE; TRANSGENE; TUMOR SUPPRESSOR GENE; VIRAL GENE DELIVERY SYSTEM; ANIMAL; CELL LINE; CHROMOSOME 3; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; MOUSE MUTANT; NORTHERN BLOTTING; PHYSIOLOGY; TRANSACTIVATION;

ANIMALS; BLOTTING, NORTHERN; CARRIER PROTEINS; CELL LINE; CHROMOSOMES, HUMAN, PAIR 3; GENE EXPRESSION REGULATION; GENES, TUMOR SUPPRESSOR; HUMANS; MICE; MICE, SCID; NEOPLASM PROTEINS; NUCLEAR PROTEINS; PROTEIN-SERINE-THREONINE KINASES; TETRACYCLINE; TRANS-ACTIVATION (GENETICS);

EID: 0036635757     PISSN: 1099498X     EISSN: None     Source Type: Journal    
DOI: 10.1002/jgm.283     Document Type: Article

References (32)

1. Imreh S, Kholodnyuk I, Allikmetts R, et al. Nonrandom loss of human chromosome 3 fragments from mouse-human microcell hybrids following progressive growth in SCID mice. Genes Chromosomes Cancer 1994; 11: 237-245.
2. Szeles A, Yang Y, Sandlund AM, et al. Human/mouse microcell hybrid based elimination test reduces the putative tumor suppressor region at 3p21.3 to 1.6 cM. Genes Chromosomes Cancer 1997; 20: 329-336.
3. Li J, Protopopov AI, Gizatullin RZ, et al. Identification of new tumor suppressor genes based on in vivo functional inactivation of a candidate gene. FEBS Lett 1999; 451 289-294.
4. Gossen M, Bujard H. Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc Natl Acad Sci U S A 1992; 89: 5547-5551.
5. Kistner A, Gossen M, Zimmermann F, et al. Doxycycline-mediated quantitative and tissue-specific control of gene expression in transgenic mice. Proc Natl Acad Sci U S A 1996; 93 10933-10938.
6. Todd MC, Xiang RH, Garcia DK, et al. An 80 Kb P1 clone from chromosome 3p21.3 suppresses tumor growth in vivo. Oncogene 1996; 13: 2387-2396.
7. Sambrook J, Fritsch EF, Maniatis T. Molecular Cloning: a Laboratory Manual. Cold Spring Harbor Laboratory Press: Cold Spring Harbor, New York, 1989.
8. Protopopov AI, Gizatullin RZ, Vorobieva NV, et al. Human chromosome 3: high-resolution fluorescence in situ hybridization mapping of 40 unique Notl linking clones homologous to genes and cDNAs. Chromosome Res 1996; 4: 443-447.
9. Vanin EF, Cerruti L, Tran N, et al. Development of high-titer retroviral producer cell lines by using Cre-mediated recombination. J Virol 1997; 71: 7820-7826.
10. Pacheco TR, Maxwell F, Vasiloudes PE, et al. Positive tetracycline control of expression of p15INK4B from an Epstein-Barr autonomous plasmid in a human melanoma cell line. Gene 2000; 242 249-256.
11. Gopalkrishnan RV, Christiansen KA, Goldstein NI, DePinho RA, Fisher PB. Use of the human EF-1alpha promoter for expression can significantly increase success in establishing stable cell lines with consistent expression: a study using the tetracycline-inducible system in human cancer cells. Nucl Acids Res 1999; 27: 4775-4782.
12. Szeles A, Bajalica-Lagercrantz S, Lindblom A, et al. Mapping of a new MAP kinase activated protein kinase gene (3PK) to human chromosome band 3p21.2 and ordering of 3PK and two cosmid markers in the 3p22-p21 tumour-suppressor region by two-colour fluorescence in situ hybridization. Chromosome Res 1996; 4: 310-313.
13. Wei MH, Latif F, Bader S, et al. Construction of a 600-kilobase cosmid clone contig and generation of a transcriptional map surrounding the lung cancer tumor suppressor gene (TSG) locus on human chromosome 3p21.3: progress toward the isolation of a lung cancer TSG. Cancer Res 1996; 56: 1487-1492.
14. Sithanandam G, Latif F, Duh FM, et al. 3pK, a new mitogen-activated protein kinase-activated protein kinase located in the small cell lung cancer tumor suppressor gene region. Mol Cell Biol 1996; 16: 868-876.
15. Ludwig S, Engel K, Hoffmeyer A, et al. 3pK, a novel mitogen-activated protein (MAP) kinase-activated protein kinase, is targeted by three MAP kinase pathways. Mol Cell Biol 1996; 16 6687-6697.
16. Neufeld B, Grosse-Wilde A, Hoffmeyer A, et al. Serine/threonine kinases 3pK and MAPK-activated protein kinase 2 interact with the basic helix-loop-helix transcription factor E47 and repress its transcriptional activity. J Biol Chem 2000; 275: 20239-20242.
17. Tomita Y, Kawasaki T, Bilim V, Takeda M, Takahashi K. Tetrapeptide DEVD-aldehyde or YVAD-chloromethylketone inhibits Fas/Apo-1(CD95)-mediated apoptosis in renal-cell-cancer cells. Int J Cancer 1996; 68: 132-135.
18. Dreijerink K, Braga E, Kuzmin I, et al. The candidate tumor suppressor gene, RASSF1A, from human chromosome 3p21.3 is involved in kidney tumorigenesis. Proc Natl Acad Sci U S A 2001; 98: 7504-7509.
19. Alimov A, Kost-Alimova M, Liu J, et al. Combined LOH/CGH analysis proves the existence of interstitial 3p deletions in renal cell carcinoma. Oncogene 2000; 19: 1392-1399.
20. Tannegård P, Zabarovsky E, Stanbridge E, Nordenskjöld M, Lindblom A. Sublocalization of a locus at 3p21.3 predisposing to hereditary non-polyposis colon cancer. Hum Genet 1994; 94: 210-214.
21. Cook WD, McCaw BJ. Accommodating haploinsufficient tumor suppressor genes in Knudson's model. Oncogene 2000; 19: 3434-3438.
22. Kholodnyuk I, Szeles A, Yang Y, Klein G, Imreh S. Inactivation of the human fragile histidine triad gene at 3p14.2 in monochromosomal human/mouse microcell hybrid-derived severe combined immunodeficient mouse tumors. Cancer Res 2000; 60: 7119-7125.
23. Strathdee G, Appleton K, Illand M, et al. Primary ovarian carcinomas display multiple methylator phenotypes involving known tumor suppressor genes. Am J Pathol 2001; 158: 1121-1127.
24. Dammann R, Li C, Yoon JH, et al. Epigenetic inactivation of a RAS association domain family protein from the lung tumour suppressor locus 3p21.3. Nat Genet 2000; 25: 315-319.
25. Satoh H, Lamb PW, Dong JT, et al. Suppression of tumorigenicity of A549 lung adenocarcinoma cells by human chromosomes 3 and 11 introduced via microcell-mediated chromosome transfer. Mol Carcinog 1993; 7: 157-164.
26. Cheng Y, Poulos NE, Lung ML, et al. Functional evidence for a nasopharyngeal carcinoma tumor suppressor gene that maps at chromosome 3p21.3. Proc Natl Acad Sci U S A 1998; 95: 3042-3047.
27. Ishikawa S, Kai M, Tamari M, et al. Sequence analysis of a 685-kb genomic region on chromosome 3p22-p21.3 that is homozygously deleted in a lung carcinoma cell line. DNA Res 1997; 28: 35-43.
28. Latif F, Tory K, Modi WS, et al. Molecular characterization of a large homozygous deletion in the small cell lung cancer cell line U2020: a strategy for cloning the putative tumor suppressor gene. Genes Chromosomes Cancer 1992; 5: 119-127.
29. Wistuba II, Behrens C, Virmani AK, et al. High resolution chromosome 3p allelotyping of human lung cancer and preneoplastic/preinvasive bronchial epithelium reveals multiple, discontinuous sites of 3p allele loss and three regions of frequent breakpoints. Cancer Res 2000; 60: 1949-1960.
30. Partridge M, Emilion G, Pateromichelakis S, Phillips E, Langdon J. Location of candidate tumour suppressor gene loci at chromosomes 3p, 8p and 9p for oral squamous cell carcinomas. Int J Cancer 1999; 83: 318-325.
31. Dammann R, Yang G, Pfeifer GP. Hypermethylation of the CpG island of Ras association domain family 1A (RASSF1A), a putative tumor suppressor gene from the 3p21.3 locus, occurs in a large percentage of human breast cancers. Cancer Res 2001; 61: 3105-3109.
32. Dubbink HJ, Verkaik NS, Faber PW, et al. Tissue specific and androgen-regulated expression of human prostate-specific transglutaminase. Biochem J 1996; 5 (Pt 3): 901-908. f